Vir Biotechnology Inc (VIR)
8.13
+0.03
(+0.37%)
USD |
NASDAQ |
Apr 23, 16:00
8.13
0.00 (0.00%)
After-Hours: 20:00
Vir Biotechnology Price: 8.13 for April 23, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Apr 22, 2024 | 8.02 | 8.40 | 7.91 | 8.10 | 1.086M |
Apr 19, 2024 | 7.95 | 8.205 | 7.755 | 7.95 | 1.080M |
Apr 18, 2024 | 8.22 | 8.31 | 7.94 | 7.96 | 1.067M |
Apr 17, 2024 | 8.45 | 8.53 | 8.207 | 8.25 | 772460.0 |
Apr 16, 2024 | 8.48 | 8.565 | 8.34 | 8.36 | 660988.0 |
Apr 15, 2024 | 8.97 | 8.985 | 8.44 | 8.57 | 770040.0 |
Apr 12, 2024 | 9.20 | 9.23 | 8.84 | 8.97 | 781830.0 |
Apr 11, 2024 | 9.18 | 9.39 | 9.01 | 9.24 | 745441.0 |
Apr 10, 2024 | 9.22 | 9.26 | 9.001 | 9.09 | 912339.0 |
Apr 09, 2024 | 9.51 | 9.905 | 9.425 | 9.53 | 618812.0 |
Apr 08, 2024 | 9.40 | 9.50 | 9.22 | 9.49 | 649675.0 |
Apr 05, 2024 | 9.29 | 9.46 | 9.20 | 9.34 | 529004.0 |
Apr 04, 2024 | 9.77 | 9.88 | 9.445 | 9.47 | 909208.0 |
Apr 03, 2024 | 9.47 | 9.70 | 9.27 | 9.69 | 1.159M |
Apr 02, 2024 | 9.97 | 9.97 | 9.60 | 9.62 | 1.000M |
Apr 01, 2024 | 10.14 | 10.29 | 9.91 | 10.20 | 740820.0 |
Mar 28, 2024 | 10.16 | 10.34 | 10.02 | 10.13 | 738256.0 |
Mar 27, 2024 | 10.01 | 10.24 | 9.78 | 10.10 | 995069.0 |
Mar 26, 2024 | 10.11 | 10.21 | 9.96 | 9.97 | 603634.0 |
Mar 25, 2024 | 9.99 | 10.11 | 9.94 | 10.00 | 442588.0 |
Mar 22, 2024 | 10.09 | 10.18 | 9.96 | 10.05 | 511002.0 |
Mar 21, 2024 | 10.28 | 10.48 | 10.07 | 10.09 | 847991.0 |
Mar 20, 2024 | 9.86 | 10.28 | 9.77 | 10.17 | 906544.0 |
Mar 19, 2024 | 10.70 | 10.84 | 9.865 | 10.00 | 1.350M |
Mar 18, 2024 | 10.90 | 10.90 | 10.59 | 10.68 | 1.112M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
7.76
Minimum
Oct 27 2023
83.07
Maximum
Jan 27 2021
28.64
Average
26.74
Median
Price Benchmarks
Vertex Pharmaceuticals Inc | 404.59 |
Vistagen Therapeutics Inc | 4.805 |
Immuneering Corp | 1.64 |
SeaStar Medical Holding Corp | 0.4859 |
NovaBay Pharmaceuticals Inc | 0.076 |
Price Related Metrics
PS Ratio | 27.61 |
Price to Book Value | 0.6903 |
Earnings Yield | -56.46% |
Market Cap | 1.098B |